Determinants of long-term follow-up after stent implantation in acute myocardial infarction;Determinanten des langzeitverlaufes über drei jahre nach stent-implantation bei akutem myokardinfarkt

Zeitschrift fur Kardiologie

Volumn 91, Issue 11, 2002, Pages 905-912

  Heidland, Ulrich E ^a   Michel, C J ^a   Aktug, O ^a   Heintzen, M P ^a   Strauer, B E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Long term follow up; Myocardial infarction; Predictors; Stent

Indexed keywords

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY BLOOD VESSEL; CORONARY STENT; DEATH; FEMALE; FOLLOW UP; GENDER; HEART INFARCTION; HUMAN; HYPERTENSION; IMPLANTATION; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RESTENOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VASCULAR DISEASE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETREATMENT; RETROSPECTIVE STUDIES; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036454451     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-002-0845-8     Document Type: Article

References (23)

1. Grines CL, Browne KF, Marco J et al (1993) A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 328:673-679
2. Gusto II b angioplasty substudy investigators (1997) A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 336:1621-1628
3. Stone GW, Grines CL, Browne KF et al (1995) Predictors of in-hospital and 6 months outcome after acute myocardial infarction in the reperfusion era: The Primary Angioplasty in Myocardial Infarction (PAMI) Trial. J Am Coll Cardiol 25:370-377
4. Stone GW, Brodie BR, Griffin JJ et al (1999) Clinical and angiographic follow-up after primary stenting in acute myocardial infarction: The Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial. Circulation 99:1548-1554
5. Maillard L, Hamon M, Khalife K et al (2000) A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Stentim-2 Investigators. J Am Coll Cardiol 35:1729-1736
6. Rodriguez A, Bernardi V, Fermandez M et al (1998) In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Am J Cardiol 81:1286-1291
7. Antoniucci D, Santoro GM, Bolognese L et al (1998) A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: Results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRES-CO) trial. J Am Coll Cardiol 31:1234-1239
8. Schomig A, Kastrati A, Dirschinger J et al (2000) Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med 343:385-391
9. Kastrati A, Pache J, Dirschinger J et al (2000) Primary intracoronary stenting in acute myocardial infarction: Long-term clinical and angiographic follow-up and risk factor analysis. Am Heart J 139:208-216
10. Gillman MW, Kannel WB, Belanger A et al (1993) Influence of heart rate on mortality among persons with hypertension: The Framingham Study. Am Heart J 125:1148-1154
11. Strauer BE, Schwartzkopff B (1998) Objectives of high blood pressure treatment: Left ventricular hypertrophy, diastolic function and coronary reserve. Am J Hypertens 11:879-881
12. Verdecchia P, Schilaci G, Borgioni C et al (1998) Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 97:48-54
13. Heidland UE, Strauer BE (2001) Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 104:1477-1482
14. Van Belle E, Bauters C, Hubert E (1997) Restenosis rates in diabetic patients. A comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 96:1454-1460
15. Heidland UE, Heintzen MP, Klimek WJ, Michel CJ, Strauer BE (1998) Acute complications and restenosis in women undergoing PTCA. Is it possible to define sex differences and to determine risk factors? J Cardiovasc Risk 5:297-302
16. Weintraub WS, Wenger NK, Kosinski AS, Douglas JS, Liberman HA, Morris DC et al (1994) Percutaneous transluminal coronary angioplasty in women compared with men. J Am Coll Cardiol 24:81-90
17. Vandormael MG, Ubeydullah D, Kern MJ (1987) Multilesion coronary angioplasty: Clinical and angiographic follow-up. J Am Coll Cardiol 10:246-252
18. Savage MP, Douglas JS, Fischman DL, Pepine CJ, King SB, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S (1997) Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 337:740-747
19. Heidland UE, Heintzen MP, Michel CJ, Strauer BE (2001) Risk factors for the development of restenosis following stent implantation of venous bypass grafts. Heart 85:312-317
20. Lee KL, Woodlief LH, Topol EJ et al (1995) Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41021 patients. Circulation 91:1659-1668
21. Bauters C, Hubert E, Prat A, Bougrimi K, van Belle E, Mc Fadden E, Amouyel P, Lablanche JM, Bertrand M (1998) Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 31:1291-1298
22. Cannon CP, Braunwald EJ (1996) Time to reperfusion: The critical modulator in thrombolysis and primary angioplasty. J Thromb Thrombolysis 3:117-125
23. Lefkovits J, Ivanhoe RJ, Califf RM et al (1996) Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and 6-month outcomes after percutaneous transluminal angioplasty for acute myocardial infarction. Am J Cardiol 77:1045-1051